Mary Miller sold $585 of ACRV
Chief Legal Officer at Acrivon Therapeutics, Inc.. 294 shares at an average of $1.99, traded Oct 5, 2026, filed Oct 7, 2026.
Score components
- +15RoleOfficer
- 0Trade size$585 at market
- 0Share of holdings soldSold 0.4% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000905148-26-004399, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 5, 2026 | SOpen-market sale Common Stock | -294 | $1.99 | $585 | 81,715 | 5 d ago |
Related signals
Other insiders at Acrivon Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 42Moderate | ACRVsell Acrivon Therapeutics, Inc. | Perceptive Advisors LLC owner | $1.0M 736,767 shares | -19% | |
| 47Moderate | ACRVsell Acrivon Therapeutics, Inc. | Perceptive Advisors LLC owner | $2.7M 1,519,952 shares | -28% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.